Rifabutin
Overview
Rifabutin is rifamycin antibiotic with a spectrum of antibacterial activity similar to that of rifampicin. Rifabutin is used for the prophylaxis of Mycobacterium avium complex (MAC) infection in immunocompromised patients and for the treatment of opportunistic mycobacterial infections including tuberculosis (T.B).
Categories
- 6 Anti-infective drugs
- 6.2 Antibiotics, systemic
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Rifabutin's dosage details are as follows:
Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
No data regarding the Adult dosage details of Rifabutin is available. |
Paedriatic Dosage (20kg)
|
No data regarding the Paedriatic dosage details of Rifabutin is available. |
Neonatal Dosage (3kg)
|
No data regarding the neonatal dosage details of Rifabutin is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Rifabutin
Back to top
Previous Drug Generic - Next Drug Generic